
### [MONDO:0005171](http://purl.obolibrary.org/obo/MONDO_0005171)
**Label:** chronic myeloproliferative disorder

**Subclasses:** [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0005029](http://purl.obolibrary.org/obo/MONDO_0005029) (essential thrombocythemia), [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0009692](http://purl.obolibrary.org/obo/MONDO_0009692) (primary myelofibrosis), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0011996](http://purl.obolibrary.org/obo/MONDO_0011996) (chronic myelogenous leukemia), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), 

**Corr. equiv. classes:** [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [Orphanet:3318](http://www.orpha.net/ORDO/Orphanet_3318), [OMIM:300331](http://purl.obolibrary.org/obo/OMIM_300331), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [Orphanet:824](http://www.orpha.net/ORDO/Orphanet_824), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [OMIM:608232](http://purl.obolibrary.org/obo/OMIM_608232), [Orphanet:521](http://www.orpha.net/ORDO/Orphanet_521), 

**Class expressions from DL-Learner:**

- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0100495](http://purl.obolibrary.org/obo/HP_0100495) (Mastocytosis))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0100494](http://purl.obolibrary.org/obo/HP_0100494) (Abnormal mast cell morphology))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0100326](http://purl.obolibrary.org/obo/HP_0100326) (Immunologic hypersensitivity))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0031466](http://purl.obolibrary.org/obo/HP_0031466) (Impairment in personality functioning))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0012531](http://purl.obolibrary.org/obo/HP_0012531) (Pain))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0011843](http://purl.obolibrary.org/obo/HP_0011843) (Abnormality of skeletal physiology))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0002014](http://purl.obolibrary.org/obo/HP_0002014) (Diarrhea))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0000716](http://purl.obolibrary.org/obo/HP_0000716) (Depressivity))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0000708](http://purl.obolibrary.org/obo/HP_0000708) (Behavioral abnormality))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 58.30%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0200151](http://purl.obolibrary.org/obo/HP_0200151) (Cutaneous mastocytosis))) 53.73%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and (not ([HP:0100845](http://purl.obolibrary.org/obo/HP_0100845) (Anaphylactic shock))) 53.73%


